Trial
NCT03301415
Asymptomatic Congenital CMV Treatment
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Congenital Cytomegalovirus Infection
Intervention
Valganciclovir
Why stopped
Safety signal
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-26